Crescita Therapeutics Inc.
CRRTF
$0.2371
-$0.1155-32.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.87% | -4.90% | 20.53% | -223.47% | -130.08% |
| Total Depreciation and Amortization | -13.87% | -6.42% | -18.61% | -20.39% | 2.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.45% | -67.78% | 96.65% | -72.92% | -140.87% |
| Change in Net Operating Assets | -80.30% | 259.51% | 3.83% | 431.46% | -62.06% |
| Cash from Operations | -227.46% | 612.51% | 233.58% | 562.85% | -82.20% |
| Capital Expenditure | -- | -226.68% | -2,818.66% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -226.68% | -2,544.98% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.41% | -7.62% | -6.80% | -8.91% | -9.09% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 44.87% | 49.67% | 51.25% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 36.69% | 9.60% | 31.13% | -53.59% | -139.07% |
| Foreign Exchange rate Adjustments | -30.00% | 521.59% | -176.22% | 113.43% | -18.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -572.85% | 227.59% | -175.39% | -939.18% | -92.81% |